All In Biotech

Investigational drug · Phase 2

Sunobinop

Also called: V117957

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Alcohol Use Disorder.

Phase 2

Last checked: Nov 19, 2026Latest source record: Jul 7, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

2

0 still active

All registered trials

3

Any phase or sponsor naming "Sunobinop"

First trial start

2024

Oct 14, 2024

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Sunobinop", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Alcohol Use Disorder

Approved drugs for the same conditions: Alcohol dependence · Psychiatry

Largest trials

Live from ClinicalTrials.gov: studies naming "Sunobinop" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 8 on PubMed

Also in development for Alcohol Use Disorder

  • BrenipatideLY3537031Phase 313 trials

    Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major

  • MazdutideLY3305677Phase 35 trials

    Eli Lilly · Type 2 Diabetes, Obesity, Overweight

  • CMND-100MEAIPhase 21 trial

    Clearmind Medicine Inc. · Alcohol Use Disorder

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.